Purple Biotech Ltd (PPBT) - סך כל נכסי החברה

Purple Biotech (PPBT) focuses on developing targeted therapies to combat resistant tumors by influencing their microenvironment. This chart reflects an asset value of 24.27, demonstrating the company's total assets. Business resilience depends on the outcomes of tests for pancreatic cancer drugs, while the Israeli management efficiently allocates existing capital to minimize operating expenses.

To minimize risks while preserving capital, it is essential to track the total value of Purple Biotech (PPBT) resources and liabilities, which is reverse-calculated via ROA, allowing the scale of the business and the company's fundamental stability to be determined by the total asset value during periods of high pressure on the R&D pipeline while conducting clinical trials for the oncology drugs CM24 and NT219.